Skip to menu Skip to content Skip to footer

Targeting metstatic breast cancer by oligonucleotide therapeutics with the FDA lipid nanoparticles (LNP) delivery system. (2024-2027)

Experts

Dr Ben Rashidieh

Honorary Research Fellow
Mater Research Institute-UQ
Faculty of Health, Medicine and Behavioural Sciences
Ben Rashidieh
Ben Rashidieh

Honorary Professor Kum Kum Khanna

Honorary Professor
Mater Research Institute-UQ
Faculty of Health, Medicine and Behavioural Sciences
Kum Kum Khanna